Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-11-23

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal's original application for a generic oxybutynin chloride product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)